FibroBiologics
Growth Stage
The Future of Cell Therapy
Overview
Raised: $4,999,819
Total Commitments ($USD)
Platform
StartEngine
Start Date
01/30/2023
Close Date
04/04/2023
Min. Goal
$10,000
Max. Goal
$4,999,999
Min. Investment
$499
Security Type
Equity - Preferred
Series
Seed
SEC Filing Type
RegCF
Price Per Share
$1.69
Pre-Money Valuation
$252,568,627
Rolling Commitments ($USD)
Status
Funded
Reporting Date
04/29/2023
Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise
$79,362
# of Investors
718
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2021
Industry
Healthcare & Pharmaceuticals
Tech Sector
Biotech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
FibroBiologics, with a valuation of $252.6 million, is raising funds on StartEngine. It is a cell therapy biotech and pharmaceutical company with five product candidates in the pipeline. The product candidates of FibroBiologics target different medical areas, including degenerative disc disease, multiple sclerosis, wound healing, cancer, and extension of life applications. FibroBiologics has over 160 U.S. and international patents and may get approval for its first product in 2023. Peter O’Heeron founded FibroBiologics in April 2021. The current crowdfunding campaign has a minimum target of $9,999.73 and a maximum target of $5 million. The campaign proceeds will be used for research and development and administration expenses.
Summary Profit and Loss Statement
| FY 2021 | FY 2020 | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-1,582,000 |
$-1,169,000 |
Summary Balance Sheet
| FY 2021 | FY 2020 | |
|---|---|---|
|
Cash |
$407,000 |
$0 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$468,000 |
$0 |
|
Short-Term Debt |
$1,758,000 |
$0 |
|
Long-Term Debt |
$0 |
$0 |
|
Total Liabilities |
$1,758,000 |
$0 |
Financials as of: 01/30/2023
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Ratings 
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.